COLL vs ULTA · P/E 17, rev $181.9M vs P/E 17, rev $11.30B
Collegium Pharmaceutical Inc (COLL) versus Ulta Beauty Inc (ULTA) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Ulta Beauty Inc (ULTA) is a specialty retail company listed on NASDAQ.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported ULTA revenue for 2025-02-01 was $11.30B. Net income was $1.20B. Revenue was up 0.8% from 2024-02-03 to 2025-02-01. ULTA currently screens at market cap $19.38B and trailing P/E 16.9.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. ULTA currently screens at market cap $19.38B and trailing P/E 16.9.
Not investment advice. Open the COLL and ULTA stock pages for the full models.
Not investment advice.